Inicio › Cáncer de pulmón de células no pequeñas › California › Newport Beach
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Newport Beach, CA
14 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Newport Beach y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
ReclutandoFase 3
- Hoag Hospital Newport Beach, Newport Beach
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
ReclutandoFase 1
- Research Site, Newport Beach
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
ReclutandoFase 3
- Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
ReclutandoFase 1
- Research Site, Newport Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ReclutandoEstudio observacional
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of KK2269 in Adult Participants With Solid Tumors
ReclutandoFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 3
- Hoag Memorial Hospital, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- Hoag Family Cancer Institute, Newport Beach
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
ReclutandoFase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
ReclutandoFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ReclutandoFase 3
- Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
ReclutandoFase 2
- City of Hope at Newport Beach Fashion Island, Newport Beach
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Newport Beach
- Cáncer de seno16 estudios
- Cáncer metastásico10 estudios
- Enfermedad de obstrucción pulmonar crónica9 estudios
- Cáncer de ovario9 estudios
- Cáncer de endometrio7 estudios
- Cáncer de pulmón7 estudios
- Cáncer del colon y del recto6 estudios
- Cáncer de próstata6 estudios
- Cáncer de mama triple negativo6 estudios
- Cáncer (todos los tipos)6 estudios
- Carcinoma de células escamosas de cabeza y cuello5 estudios
- Cáncer de riñón (carcinoma de células renales)5 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.